MiddleBrook Pharmaceuticals, Inc. is a pharmaceutical company dedicated to developing and commercializing anti-infective products that address unmet medical needs. Our proprietary PULSYS® technology enables the pulsatile delivery of medications, enhancing patient compliance. We currently market KEFLEX® (cephalexin) and MOXATAG®, the first and only FDA-approved once-daily amoxicillin. https://middlebrookpharma.com/